Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma

Cell Reports(2020)10.1016/j.celrep.2019.12.071Source: DataRank Database

Chromosome 3q26 Gain Is an Early Event Driving Coordinated Overexpression of the PRKCI, SOX2, and ECT2 Oncogenes in Lung Squamous Cell Carcinoma is a research paper published in Cell Reports (2020). On theSindex it has a DataRank of 0. It has been cited 46 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access46 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (10 grants)Impact (FWCI 3.52)OA: goldTopics (67)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Ning Yin ORCID,Xue Wang ORCID,András Khoór ORCID,Vaishnavi Sambandam ORCID,Anwesha Ghosh ORCID

Live enrichment

PubMed:31968252 PMC:PMC7238436 OpenAlex:https://openalex.org/W3001412183

American Cancer Society

Grant: RSG-18-201-01

National Cancer Institute

Grant: R01 CA081436-22

National Cancer Institute

Grant: R01 CA140290-05

National Cancer Institute

Grant: R01 CA206267-04

National Cancer Institute

Grant: R03 CA235189

NCI NIH HHS

Grant: R01 CA140290

NCI NIH HHS

Grant: R01 CA206367

NCI NIH HHS

Grant: R01 CA081436

Mayo Clinic

National Institutes of Health

FWCI

3.52

Citation Percentile

0.9%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttp://www.cell.com/article/S2211124719317280/pdf

publisherhttp://www.cell.com/article/S2211124719317280/pdf

publisherhttps://api.elsevier.com/content/article/PII:S2211124719317280?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S2211124719317280?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.celrep.2019.12.071

Fields of Study

Genomic variations and chromosomal abnormalitiesEpigenetics and DNA MethylationRNA modifications and cancerCarcinogenesisCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellCell Line, TumorCell ProliferationCell Transformation, NeoplasticChromosomes, Human, Pair 3Gene DosageGene Expression Regulation, NeoplasticGene SilencingHumansIsoenzymesLung NeoplasmsMaleOncogenesProtein Kinase CProto-Oncogene ProteinsSOXB1 Transcription FactorsSignal TransductionTranscription, GeneticProtein Kinase C-lambda

MeSH Terms

Protein Kinase C-lambdaCarcinoma, Non-Small-Cell LungCarcinoma, Squamous CellCell Transformation, NeoplasticChromosomes, Human, Pair 3HumansIsoenzymesLung NeoplasmsMaleOncogenesProtein Kinase CProto-Oncogene ProteinsTranscription, GeneticSignal TransductionGene Expression Regulation, NeoplasticGene DosageGene SilencingCell Line, TumorCell ProliferationSOXB1 Transcription FactorsCarcinogenesis

Keywords

BiologyCarcinogenesisSOX2Cancer researchPhenotypeTumor progressionContext (archaeology)Lung cancerChromosomeGeneGeneticsPathologyTranscription factorMedicineCngOncogenic TransformationLsccLung Squamous Cell CarcinomaEct2Prkci3Q26 Copy Number GainLung Basal Stem Cells

Sustainable Development Goals

SDG 0: Good health and well-being